Author： Ryton Beverly A Liddle B Jane
Publisher： Royal College Of Physicians
ISSN： 1470-2118
Source： Clinical Medicine, Vol.9, Iss.5, 2009-10, pp. : 436-440
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Tolcapone in Parkinson’s disease: liver toxicity and clinical efficacy
By Borges Nuno
Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. :
Clinical Pharmacology, Therapeutic Use and Potential of COMT Inhibitors in Parkinsons Disease
By Kaakkola S.
Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. :
Dopaminergic substitution in Parkinson’s disease
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. :